[关键词]
[摘要]
目的:探讨姜黄素(curcumin,Cur)对人多发性骨髓瘤ARH-77细胞外源性凋亡通路的影响。方法:ARH-77细胞经6.25、12.5、25、50、100、200 μmol/L Cur处理12、24、48 h,MTT法检测Cur对ARH-77细胞增殖的抑制作用,Hoechst 33258染色法观察Cur处理24 h后ARH-77细胞凋亡的形态学改变,流式细胞术检测ARH-77细胞周期和Fas/FasL、TRAIL/TRAIL-R的表达,分光光度法检测ARH-77细胞caspase-8的活性。结果:Cur对ARH-77细胞的增殖有时间和剂量依赖的抑制作用。25 μmol/L Cur处理ARH-77细胞可观察到凋亡小体,Cur阻滞细胞周期于G0/G1期,并且有凋亡峰。其促凋亡作用呈浓度依赖性,6.25、12.5、25 μmol/L Cur作用24 h后,ARH-77细胞凋亡率均显著高于对照组\[(10.35±0.35)%、(14.35±1.34)%、(36.65±1.06)% vs(3.83±0.32)%,F=500.432, P=0.000\];实验组细胞内caspase 8的活化程度均显著高于对照组\[(0223±0.018)、(0.263±0.019)、(0.240±0.035) vs (0.154±0.007);F=9.059,P=20.03\]。12.5 μmol/L Cur作用24 h后,ARH-77细胞表面Fas\[(99.05±0.49)% vs(92.10±0.70)%,t=15.404, P=0.000\]、FasL \[(9.05±0.78)% vs(1.73±119)%,t=9.487, P=0.008\]、TRAIL\[(1.35±0.07)% vs(0.55±0.07)%,t=-11.317, P=0.008\]、DR4、DcR1和DcR2的表达均显著升高,DR5表达显著降低\[(0.95±0.07)% vs(7.70±0.29)%,t=32.742, P=0.001\];进一步提升Cur浓度至25 μmol/L,却降低了DcR1\[(4.35±120)% vs (14.25±021)%;t=5.692, P=0.008\]及DcR2\[(0.75±0.21)% vs (1.65±071)%;t=11.470, P=0.03\]的表达。结论:Cur能明显抑制人多发性骨髓瘤ARH-77细胞的增殖,其机制可能与激活外源性凋亡通路从而诱导细胞凋亡有关。
[Key word]
[Abstract]
Objective:To investigate the influence of curcumin (Cur) on the extrinsic apoptosis pathway of human multiple myeloma cell line ARH-77. Methods: ARH-77 cells were treated with Cur at 6.25, 12.5, 25, 50, 100 and 200 μmol/L. At 12, 24 and 48 h after treatment, cell viability was analyzed by MTT assay and growth inhibition was accordingly calculated. At 24 h after treatment, changes in the cell morphology were assessed by Hoechst 33258 staining, cell cycle progression and levels of Fas/Fasl and TRAIL/TRAIL-R were analyzed by flow cytometry, and the activity of caspase 8 was determined by colorimetry. Results: Cur significantly inhibited the growth of ARH-77 cells in a time- and dose-dependent manner. At 24 h after treatment, Cur induced apoptosis in ARH-77 cells in a dose-dependent manner; the percentage of apoptotic cells was (10.35±0.35)% at 6.25 μmol/L, (1435±1.34)% at 12.5 μmol/L and (36.65±106)% at 25 μmol/L, significantly higher than that in untreated control cells (\[3.83±0.32\]%, P<0.01). Apoptotic bodies and cell cycle arrest at the G0/G1 phase were seen in ARH-77cells treated with 25 μmol/L Cur. Caspase 8 activity was significantly higher in ARH-77 cells treated with Cur at 6.26 μmol/L(0.223±0.018), 12.5 μmol/L (0.263±0.019), or 25.0 μmol/L (0.240±0.035) than in untreated control cells (0.154±0.007) (P<0.05). Compared with the non-treatment control, 24 h Cur treatment at 6.25 μmol/L significantly increased the protein levels of Fas (\[99.05±0.49\]% vs \[92.10±0.7\]%, P=0.000), FasL (\[9.05±0.78\]% vs \[1.73±1.19\]%, P=0008), TRAIL (\[1.35±0.07\]% vs \[0.55±0.07\]%, P=0.008), DR4, DcR1 and DcR2 but significantly decreased DR5 (\[0.95±0.07\]% vs \[7.70±0.29]%, P=0.001). The effect of Cur on DcR1 (\[4.35±1.20\]% vs \[14.25±0.21\]%, P=0.008) and DcR2 (\[0.75±0.21\]% vs \[1.65±0.71\]%, P=0.03) were more pronounced at 25.0 μmol/L than at 12.5 μmol/L. Conclusion: Cur is able to inhibit the growth of ARH-77 cells through activating the extrinsic apoptosis pathway and thereby may offer a potential therapeutic agent for multiple myeloma.
[中图分类号]
[基金项目]
广州市医药卫生科技项目(No. 20121A011102)